MRI volumetric and intensity analysis of the cerebellum in Parkinson's disease patients infused with glial-derived neurotrophic factor (GDNF)

Experimental Neurology

Volumn 198, Issue 2, 2006, Pages 450-456

  Chebrolu, H ^a   Slevin, J T ^a   Gash, D A ^a   Gerhardt, G A ^a   Young, B ^a   Given, C A ^a   Smith, C D ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Cerebellar lesions; Difference image analysis; Histogram analysis; Longitudinal study; VBM

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ANALYSIS OF VARIANCE; ARTICLE; BRAIN REGION; BRAIN SIZE; CEREBELLUM; CEREBELLUM DISEASE; CEREBELLUM INJURY; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; FEMALE; GRAY MATTER; HUMAN; IMAGE ANALYSIS; LONGITUDINAL STUDY; MALE; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; CASE-CONTROL STUDIES; CEREBELLUM; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INDIVIDUALITY; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 33645744212     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2005.12.021     Document Type: Article

References (23)

1. Almeida O.P., Burton E.J., McKeith I., Gholkar A., Burn D., and O'Brien J.T. MRI study of caudate nucleus volume in Parkinson's disease with and without dementia with Lewy bodies and Alzheimer's disease. Dementia Geriatr. Cognit. Disord. 16 (2003) 57-63
2. Ashburner J., Andersson J.L., and Friston K.J. Image registration using a symmetric prior-In three dimensions. Hum. Brain Mapp. 9 (2000) 212-225
3. Bottcher J. Morphology of the basal ganglia in Parkinson's disease. Acta Neurol. Scand., Suppl. 62 (1975) 1-87
4. Good C.D., Johnsrude I.S., Ashburner J., Henson R.N., Friston K.J., and Frackowiak R.S. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage 14 (2001) 21-36
5. Grondin R., Zhang Z., Yi A., Cass W.A., Maswood N., Andersen A.H., Elsberry D.D., Klein M.C., Gerhardt G.A., and Gash D.M. Chronic, controlled GDNF infusion promotes structural and functional recovery in advanced parkinsonian monkeys. Brain 125 (2002) 2191-2201
6. Hajnal J.V., Saeed N., Oatridge A., Williams E.J., Young I.R., and Bydder G.M. Detection of subtle brain changes using subvoxel registration and subtraction of serial MR images. J. Comput. Assist. Tomogr. 19 (1995) 677-691
7. Hajnal J.V., Saeed N., Soar E.J., Oatridge A., Young I.R., and Bydder G.M. A registration and interpolation procedure for subvoxel matching of serially acquired MR images. J. Comput. Assist. Tomogr. 19 (1995) 289-296
8. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 (1967) 427-442
9. Kosta P., Argyropoulou M.I., Markoula S., and Konitsiotis S. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J. Neurol. (2005) (published online)
10. Krabbe K., Karlsborg M., Hansen A., Werdelin L., Mehlsen J., Larsson H.B., and Paulson O.B. Increased intracranial volume in Parkinson's disease. J. Neurol. Sci. 239 (2005) 45-52
11. Lee J. Digital image smoothing and the sigma filter. Comput. Vis. Graph. Image Process. 24 (1983) 255-269
12. Lemieux L., Wieshmann U.C., Moran N.F., Fish D.R., and Shorvon S.D. The detection and significance of subtle changes in mixed-signal brain lesions by serial MRI scan matching and spatial normalization. Med. Image Anal. 2 (1998) 227-242
13. Lisanby S.H., McDonald W.M., Massey E.W., Doraiswamy P.M., Rozear M., Boyko O.B., Krishnan K.R., and Nemeroff C. Diminished subcortical nuclei volumes in Parkinson's disease by MR imaging. J. Neural Transm., Suppl. 40 (1993) 13-21
14. Liu R.S., Lemieux L., Bell G.S., Hammers A., Sisodiya S.M., Bartlett P.A., Shorvon S.D., Sander J.W., and Duncan J.S. Progressive neocortical damage in epilepsy. Ann. Neurol. 53 (2003) 312-324
15. LONI-Laboratory for Neuroimaging, U. ICBM 452-T1 Atlas.
16. Nutt J.G., Burchiel K.J., Comella C.L., Jankovic J., Lang A.E., Laws Jr. E.R., Lozano A.M., Penn R.D., Simpson Jr. R.K., Stacy M., and Wooten G.F. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60 (2003) 69-73
17. O'Neill J., Schuff N., Marks Jr. W.J., Feiwell R., Aminoff M.J., and Weiner M.W. Quantitative 1 H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov. Disord. 17 (2002) 917-927
18. Patel N.K., Bunnage M., Plaha P., Svendsen C.N., Heywood P., and Gill S.S. Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study. Ann. Neurol. 57 (2005) 298-302
19. Peck P. Amgen decision to halt GDNF clinical trials and withdraw the drug triggers protest from researchers and patients. Neurol. Today: Am. Acad. Neurol. (2005) 5
20. Schulz J.B., Skalej M., Wedekind D., Luft A.R., Abele M., Voigt K., Dichgans J., and Klockgether T. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann. Neurol. 45 (1999) 65-74
21. Slevin J.T., Gerhardt G.A., Smith C.D., Gash D.M., Kryscio R., and Young B. Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor. J. Neurosurg. 102 (2005) 216-222
22. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 17 (2002) 143-155
23. Zhang Y., Brady M., and Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imag. 20 (2001) 45-57